88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


PartnerOne Launches a Global Philanthropic Initiative to Expand Pediatric Surgical Care in Developing Countries PartnerOne Global Surgery (POGS) begins with a $10 million commitment from PartnerOne and an inaugural partnership with Montreal Children's Hospital, one of the most renowned pediatric hospitals in the ... 2026-05-19T Banking/Financial Service Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
ALR TECHNOLOGIES HAS LAUNCHED THE GLUCURVE PET CGM IN CANADA SINGAPORE , May 19, 2026 /PRNewswire/ -- ALR Technologies SG Ltd. (" ALRT " or the " Company ") (OTC: ALRTF), the diabetes management company, announces the GluCurve Pet CGM (" ... 2026-05-19T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Fujitsu, SMBC Group and SoftBank agree on alliance to build Japan-made platform for sustainable healthcare Companies aim to extend healthy life expectancy, optimize management of healthcare institutions, and curb national healthcare costs ... 2026-05-19T Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
BIOTRONIK, Charité, and German Heart Center Foundation Announce Partnership to Advance Digital Cardiology Strategic Initiative Strengthens Berlin as Europe's Hub of Digital Cardiology ... 2026-05-19T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Caliway Makes First ECO 2026 Oral Presentation on Preclinical Data of CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies, Attracting Strong Interest from International Experts and Global Pharmaceutical Companies for Its Systemic Metabolic Effects CBL-514, when combined separately with two leading GLP-1R-based weight-loss therapies, semaglutide and tirzepatide, demonstrated enhanced weight loss, attenuated post-discontinuation weight regain, and ... 2026-05-19T Health Care/Hospital Medical/Pharmaceuticals
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Wins Pivotal Phase III Approval, Set to Reshape the Frontline Treatment Landscape for Advanced EP-NEC NANJING, China , May 19, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that its proprietary PD-L1/4-1BB ... 2026-05-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innovent Showcased Clinical and Preclinical Results of Next-Generation Autoimmune and Ophthalmology Pipeline at the 2026 ATS and ARVO Conferences SAN FRANCISCO and SUZHOU, China , May 19, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ... 2026-05-19T Health Care/Hospital Medical/Pharmaceuticals
Accro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases F inancing led by OrbiMed with participation from TCGX, LAV, Cenova Capital and existing investors SCGC and Oriza Proceeds will advance multi-asset pipeline including AC-101, a leading RIPK2 inhibitor ... 2026-05-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment. Maximum dose reached with no dose-limiting toxicities observed. TLX101-Tx is also the subject of a pivotal ... 2026-05-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lifespan Vision Ventures Leads Violet Therapeutics' $4.75M Seed Extension Financing NORWALK, Conn. , May 19, 2026 /PRNewswire/ -- Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, today announced that it has led Violet Therapeutics' ... 2026-05-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals